Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
More Headlines
Senators introduce bill to move crypto market regulation from SEC to CFTC
BitRSS
Senators introduce bill to move crypto market regulation from SEC to CFTC
CryptoBriefing
Ethereum Derivatives Heating Up: Open Interest Registers 10% Spike
BitCoinist
Crypto.com Partners with Sui Foundation to Enhance SUI Token Custody and Liquidity Solutions
BitRSS
Biopharma eyes $100M for crypto treasury to back cancer treatment
BitRSS
Bitdeer Stock Tumbles as Bitcoin Miner Posts Third Quarter Net Loss
BitRSS